Skip to main content

Closed

BHVN: Biohaven Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-155.7%

Financially safe

Stretched

Debt / equity2.21×

Interest coverage0.0×

Current ratio7.41×

Biohaven Ltd.

BHVNNew York Stock Exchange·USD·Closed

Biohaven Ltd.

BHVNNew York Stock Exchange·USD·Closed

$13.50

−2.32%

$13.50

−$0.32 (2.32%)

52W Range

54thpctl

Volume

0.40×avg

Mkt Cap

2.03BUSD

P/E

-2.4TTM

Div Yield

–ann

52W Range

54thpctl

Volume

0.40×avg

Market Cap

2.03BUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings